Folic acid Inhibitors
Because humans do not synthesize folic acid, these antibiotics do not interfere with our own cellular metabolism.
Sulfonamides: Sulfamethoxazole, Sulfisoxazole, and Sulfadiazine
–
Gram-positive
– Gram-negative bacteria
–
Chlamydiae
–
Nocardia
– Commonly used to treat infections of the urinary and lower respiratory tracts:
MRSA pneumonia, Otitis media and some cases of gonorrhea
– Trimethoprim is often combined with sulfamethoxazole for bactericidal effects
TMP/SMX, aka, Bactrim.
– Sulfonamides competitively bind dihydropteroate synthase (in place of para-aminobenzoic acid ((PABA))
Inhibit early steps in folic acid synthesis
– Trimethoprim inhibits dihydrofolate reductase
– Enzyme modification
– Reduction of drug uptake
– Increased drug efflux
– Increased PABA synthesis
- Adverse effects of Sulfonamides
– Hypersensitivity, with potential for Stevens-Johnson syndrome or toxic epidermal necrolysis
– Drug-induced hemolytic anemia, which is more likely in individuals with G6PD deficiencies
– Nephrotoxicity
– Aseptic meningitis, specifically associated with TMP/SMX
Dapsone
–
Mycobacteria:
Leprosy, dermatitis herpetiformis, and some other skin conditions.
– Inhibits Mycobacteria folic acid synthesis via inhibition of dihydropteroate synthase.
- Adverse effects of Sulfonamides
– Hemolytic anemia, particularly in individuals with G6PD deficiencies.
para-aminosalicyclic acid (PAS)
–
Mycobacterium tuberculosis
– Inhibits folic acid synthesis
– Gastrointestinal upset
– Hypersensitivity